RU96119794A - USE OF THE MCP-1 FOR THE INDUCTION OF READINESS FOR DISPLACEMENT OF THE Cervix - Google Patents

USE OF THE MCP-1 FOR THE INDUCTION OF READINESS FOR DISPLACEMENT OF THE Cervix

Info

Publication number
RU96119794A
RU96119794A RU96119794/14A RU96119794A RU96119794A RU 96119794 A RU96119794 A RU 96119794A RU 96119794/14 A RU96119794/14 A RU 96119794/14A RU 96119794 A RU96119794 A RU 96119794A RU 96119794 A RU96119794 A RU 96119794A
Authority
RU
Russia
Prior art keywords
mcp
functional derivative
readiness
cervix
substance
Prior art date
Application number
RU96119794/14A
Other languages
Russian (ru)
Other versions
RU2207873C2 (en
Inventor
Вилльям Келли Родни
Original Assignee
Медикал Рисерч Каунсил
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9406463A external-priority patent/GB9406463D0/en
Application filed by Медикал Рисерч Каунсил filed Critical Медикал Рисерч Каунсил
Publication of RU96119794A publication Critical patent/RU96119794A/en
Application granted granted Critical
Publication of RU2207873C2 publication Critical patent/RU2207873C2/en

Links

Claims (9)

1. Применение моноцитарного хемотактического пептида-1 (МСР-1) или его функционального производного при получении лекарственного препарата для индукции готовности шейки самки млекопитающего к раскрытию.1. The use of a monocytic chemotactic peptide-1 (MCP-1) or its functional derivative in the preparation of a medicament for inducing the readiness of the neck of a female mammal for opening. 2. Применение по п. 1 в связи с родами или абортом у человека. 2. The use according to claim 1 in connection with childbirth or abortion in humans. 3. Применение по п. 1 или 2, в котором функциональное производное МСР-1 является еще одним β-хемокином. 3. The use according to claim 1 or 2, in which the functional derivative of MCP-1 is another β-chemokine. 4. Применение по любому из предшествующих пунктов, в котором МСР-1 или его функциональное производное вводится совместно с веществом, которое вызывает сокращения миометрия, или с соединением, повышающим тонус матки. 4. The use according to any one of the preceding paragraphs, in which MCP-1 or its functional derivative is administered together with a substance that causes contractions of the myometrium, or with a compound that increases the tone of the uterus. 5. Фармацевтическая композиция, которая содержит (1) МСР-1 или его функциональное производное, (2) вещество, которое вызывает сокращения миометрия, и (3) фармацевтически приемлемый носитель или растворитель. 5. A pharmaceutical composition that contains (1) MCP-1 or a functional derivative thereof, (2) a substance that causes myometrial contractions, and (3) a pharmaceutically acceptable carrier or solvent. 6. Композиция по п. 6, в которой вещество (2) является простагландином Е. 6. The composition according to claim 6, in which the substance (2) is prostaglandin E. 7. Композиция по п. 6 или 7 в виде геля, крема, микрокапсул, составов пролонгированного действия или удерживаемого освобождения, стерильного раствора для инъекций или суспензии. 7. The composition according to p. 6 or 7 in the form of a gel, cream, microcapsules, sustained release or sustained release formulations, sterile injection or suspension. 8. Агент для подготовки шейки матки к раскрытию, включающий МСР-1 или его функциональное производное. 8. An agent for preparing the cervix for disclosure, including MCP-1 or its functional derivative. 9. Способ индукции готовности к раскрытию шейки матки нуждающейся в ней самки млекопитающего, включающий введение самке млекопитающего эффективного количества МСР-1 или его функционального производного. 9. A method of inducing readiness to open the cervix of a female mammal in need of it, comprising administering to the female mammal an effective amount of MCP-1 or a functional derivative thereof.
RU96119794/14A 1994-03-31 1995-03-31 Use of mcp-1 for induction of readiness of uterus cervix to opening RU2207873C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9406463A GB9406463D0 (en) 1994-03-31 1994-03-31 Cervical ripening
GB9406463.1 1994-03-31

Publications (2)

Publication Number Publication Date
RU96119794A true RU96119794A (en) 1999-01-20
RU2207873C2 RU2207873C2 (en) 2003-07-10

Family

ID=10752860

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96119794/14A RU2207873C2 (en) 1994-03-31 1995-03-31 Use of mcp-1 for induction of readiness of uterus cervix to opening

Country Status (17)

Country Link
US (1) US5908829A (en)
EP (1) EP0752883B1 (en)
JP (1) JPH09510988A (en)
KR (1) KR100382685B1 (en)
AT (1) ATE253933T1 (en)
AU (1) AU703297B2 (en)
CA (1) CA2186370A1 (en)
DE (1) DE69532112T2 (en)
DK (1) DK0752883T3 (en)
ES (1) ES2210287T3 (en)
FI (1) FI963915A (en)
GB (1) GB9406463D0 (en)
NO (1) NO964076L (en)
NZ (1) NZ282876A (en)
PT (1) PT752883E (en)
RU (1) RU2207873C2 (en)
WO (1) WO1995026748A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) * 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
GB0103354D0 (en) * 2001-02-10 2001-03-28 Medical Res Council Biologically active agents
GB0103348D0 (en) * 2001-02-10 2001-03-28 Medical Res Council Delivery of biologically active agents
GB0210741D0 (en) * 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0224415D0 (en) * 2002-10-21 2002-11-27 Medical Res Council Compositions
US8399025B2 (en) * 2004-06-04 2013-03-19 Board Of Regents, The University Of Texas System Polyamine modified particles
US8282612B1 (en) 2008-03-07 2012-10-09 Denise H. Miller Methods and devices for intrauterine absorption
RU2501017C1 (en) * 2012-10-18 2013-12-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения и социального развития Российской Федерации Method for prediction of early miscarriage
US9078786B1 (en) 2012-10-19 2015-07-14 Denise H. Miller Methods and devices for collecting body fluids
GB201314452D0 (en) * 2013-08-13 2013-09-25 Ostara Biomedical Ltd Embryo implantation
RU2616902C1 (en) * 2016-05-26 2017-04-18 Государственное бюджетное образовательное учреждение высшего профессионального образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздрава России) Method for predicting of miscarriage of infectious genesis at early stages of gestation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531903A1 (en) * 1985-09-05 1987-03-12 Schering Ag OXYTOCIN AND ANTI-DAYS FOR THE INTRODUCTION OF BIRTH OR ON THE THERAPEUTIC STOP OF GRAVIDITY
IL92937A0 (en) * 1989-01-31 1990-09-17 Us Health Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
GB9124775D0 (en) * 1991-11-21 1992-01-15 Medical Res Council Cervical ripening
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
AU4088397A (en) * 1996-08-29 1998-03-19 Ppg Industries Ohio, Inc. Coatings for fiber strands, coated fiber strands, reinforced composites, assemblies and method of reinforcing the same

Similar Documents

Publication Publication Date Title
AU735407B2 (en) Device and method for treatment of dysmenorrhea
RU96119794A (en) USE OF THE MCP-1 FOR THE INDUCTION OF READINESS FOR DISPLACEMENT OF THE Cervix
US5698589A (en) Water-based topical cream containing nitroglycerin and method of preparation and use thereof
CO5650245A2 (en) DISPERSABLE FORMULATIONS OF AN ANTI-INFLAMMATORY AGENT
RU2560879C2 (en) Method of preventing sexually transmitted viral diseases, medication, method of obtaining medication, pharmaceutical composition for local application and condom
RO116866B1 (en) Composition for modulating the sexual response
RU97107333A (en) COMPOSITION OF THE MEDICINAL FORM FOR THE TREATMENT OF VENERAL DISEASES AND ITS APPLICATION
AU680631B2 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
FR2712807B1 (en) Solid mucoadhesive, therapeutic or hygienic composition, for administration by application to the oral or nasal mucosa.
US20030211071A1 (en) Extended, controlled-release pharmaceutical compositions using charged polymers
ES2198006T3 (en) HORMONAL COMPOSITION CONSTITUTED BY A STROGEN COMPOUND AND A PROGESTAGEN COMPOUND.
JPS5931714A (en) Contraceptive composition
Rodriguez-Martinez et al. Uterine motility in the cow during the estrous cycle. II. Comparative effects of prostaglandins F2α, E2, and cloprostenol
RU94030723A (en) Interleukin-8 use
HUP9900507A2 (en) Use of levobupivacaine for producing pharmaceutical compositions as an anaesthetic in pregnancy
AU765269B2 (en) Device and method for treatment of dysmenorrhea
ZA200503133B (en) Extended, controlled release pharmaceutical compositions comprising charged polymers
Knez Controversial contraceptive easy to insert, difficult to remove (Norplant)
RU93033148A (en) METHOD OF PREVENTION OF POST-DERIOD DISEASES OF THE Uterus in COWS
Rimbach et al. Cervical Dilatation by PGE1 Analogue Application Prior to Hysteroscopy
RU2000108551A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DYSMENOREA AND PREMATURE BIRTH
WO2001082915A2 (en) Trans-clitoral administration of therapy
VEENA et al. EVALUATION OF PGE2 GEL FOR CERVICAL RIPENING AND INDUCfION OF LABOUR
RU96121896A (en) METHOD FOR INCREASING REPRODUCTIVE FUNCTION OF COWS
RU96120483A (en) METHOD OF PREVENTION AND TREATMENT OF ENDOMETRITIS IN COWS